A detailed history of Keel Point, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Keel Point, LLC holds 1,409 shares of VRTX stock, worth $635,416. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,409
Previous 1,419 0.7%
Holding current value
$635,416
Previous $665,000 1.5%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$460.0 - $505.78 $4,600 - $5,057
-10 Reduced 0.7%
1,409 $655,000
Q2 2024

Aug 14, 2024

BUY
$392.81 - $485.53 $155,945 - $192,755
397 Added 38.85%
1,419 $665,000
Q1 2024

Apr 16, 2024

BUY
$407.69 - $446.08 $186,722 - $204,304
458 Added 81.21%
1,022 $427,000
Q4 2023

Jan 30, 2024

BUY
$343.0 - $410.68 $193,452 - $231,623
564 New
564 $229,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Keel Point, LLC Portfolio

Follow Keel Point, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keel Point, LLC with notifications on news.